Atley Solutions
2019-12-16 08:26 by Admin
Atley Solutions’ production module allows for an automated, standardised and reproducible production of astatinated radiopharmaceuticals. These pharmaceuticals are used in Targeted Alpha Therapy; a promising treatment method for disseminated cancer. The module will enhance clinical research in this field and is essential in order to enable the future treatment of cancer patients using this method. Targeted Alpha Therapy has the potential to improve and save millions of lives. For this to happen, Atley Solutions’ technology is needed.
Retein
2019-12-05 09:30 by Admin
A drop in the ocean doesn’t make any difference. Not until you realize that this drop corresponds to the fraction of water on Earth that is safe to drink. Removal of newly discovered pollutants such as microplastics and pharmaceutical residues require new ways to purify water. Or perhaps not? Retein develops water filters that harness the finest water purification process available in Nature, which is uniquely able to produce extremely pure water at low energy cost. Retein thereby aims to accommodate the needs of a billion people and industries alike by turning any source water into pure water in a cheap and environmentally friendly way.
In Singulo Solutions
2019-11-06 10:33 by Admin
In Singulo Solutions AB was founded in October 2017 following a five year collaboration of Chalmers Tekniska Högskola and AstraZeneca. In Singulo Solutions next generation of biosensing platform overcomes the limitations of current biosensing methods and advances the drug discovery and development process by delivering more relevant data significantly faster. The proprietary and awarded technology of In Singulo Solutions has already proven its advantages in developing drugs targeting the important membrane proteins. In Singulo Solutions technology has the potential to fundamentally impact the way drugs are developed. With lowered cost, higher precision and more relevant data it will allow to target diseases that are not targeted today.
Amferia
2018-11-30 09:39 by Admin
Problem
Bacterial infections are likely to surpass cancer and heart disease as a number one cause of human deaths in the future with resistant bacteria and overuse of antibiotics.
Solution
A deeptech hydrogel patch where antimicrobial peptides punctures bacterial membranes and destroys the cells without harming surrounding tissue.
Potential
Faster and safer health for animals and humans making sure to fight unnecessary deaths so that more cab survive infections. All on a truly global market.
Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia’s core focus is preventive healthcare where the goal is to provide highly efficient anti-infective medical devices that can prevent bacterial infections including those caused by antibiotic resistant bacteria. Our dominant focus is within the wound care sector, producing preventive care wound patches for the pressing need to avoid antibiotic resistant skin infections. Amferia’s proprietary anti-infective technology is a result of several years of research from Chalmers University of Technology and is patent protected.
Stayble Therapeutics
2018-11-01 15:15 by Admin
Stayble Therapeutics is a clinical-stage company developing a truly innovative, non-surgical product (STA-363) to permanently alleviate discogenic chronic low back pain (cLBP). Discogenic cLBP is globally one of the costliest and most disabling medical conditions affecting more than 50 million people on a daily basis. STA-363 is a disease-modifying, permanent, single injection treatment. The product vision of STA-363 is to become the new standard of care for patients with discogenic cLBP.
Tummy Labs
2018-11-01 14:48 by Admin
IBS is one of the most common causes to seek medical care. Even after a physician has ruled out organic disease, many patients continue to seek care because symptoms and concerns persist. This has a tremendous cost in both healthcare consumption and quality of life. Tummy Lab offers a digital education program and a decision support tool, created in collaboration with leading clinicians and researchers. The program is prescribed by the physician and carried out for six weeks in the patient’s home.
Elypta
2016-10-20 15:30 by Admin
Elypta is developing an exceptionally sensitive liquid biopsy platform for early detection and monitoring of cancer. Elypta’s assay kit enables the measurement of a novel panel of biomarkers and algorithms in Elypta’s cloud-based software, providing clinically useful scores. The first application on the market will be a blood test for early detection of recurring or progressing cancer, starting with renal cell carcinoma. The test will increase the chance of curative treatment for patients.
Promimic
2016-02-15 08:09 by Admin
Developing and marketing HAnano Surface; a surface treatment that can be used on all implants regardless of material and geometry. Composed of crystalline hydroxyapatite particles the surface has the same shape and composition as in human bone. HAnano Surface is used clinically and has proven to significantly enhance the hydrophilicity and promote osseointegration of implants. The thin surface and the innovative coating process give an exclusive product and a true differentiator in the market place.
Monivent
2015-09-09 11:13 by Admin
About 3 to 6 % of newborns require manual ventilation of the lungs to start breathing. Although both under- and overventilation can be harmful, ventilation support is one of the least controlled delivery room interventions. Monivent has developed a new technical solution complementing existing ventilation equipment, both for medical simulation training and clinical use. It provides wireless and continuous feedback on the volumes of air given to the baby supporting safe and effective ventilation.
Mevia
2015-09-09 11:06 by Admin
50 % of patients do not follow their treatment as prescribed, which can dangerously affect their health, but also ends up weighing heavy on everyone’s budget in the health-care sector. Mevia strives to boost medication adherence worldwide with connected solutions that adapt to patient needs and medication formats, as well as data analytics services. Mevia solutions enhance treatment outcomes, increase revenues of healthcare providers and enable high healthcare savings within society.